Form 4: Korro Bio Director Formela Reports Acquisition of Shares
SEC Form 4 Filing
Director Jean Francois Formela reports acquisition of 17,857 shares of Korro Bio, Inc. common stock at $56 per share on April 22, 2024.
Summary
- On April 22, 2024, Jean Francois Formela, a director of Korro Bio, Inc., reported acquiring 17,857 shares of common stock at a price of $56 per share.
- Following the transaction, Formela indirectly owns 195,074 shares through Atlas Venture Opportunity Fund II, L.P. and 942,075 shares through Atlas Venture Fund XI, L.P.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to a stock transaction by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders of a publicly traded company buy or sell the company's securities. This provides transparency to the market regarding the transactions of company insiders.
Stakeholder Impact
- The transaction provides information to shareholders regarding insider activity, which can influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/22/2024 | Date of transaction: Acquisition of common stock. |
| 04/23/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.